Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Pharm Sci 2019

About Conference


Conference Series LLC Ltd invites all the participants from all over the world to attend “19th World Congress on Advances in Pharmaceutical Sciences” during Jan 30-31, 2019 at Seoul, South Korea which includes prompt keynote presentations, Oral talks, Poster presentations, and Exhibitions. Pharm Sci 2019 offers a best platform with its well organized scientific program to the audience which includes interactive panel discussions, keynote lectures, plenary talks and poster sessions on the topics Bio-pharmaceuticals sciences, Pharmaceutical Sciences, Pharmaceutical Chemistry and Medicinal Chemistry, Biomarkers and Biosimilars in Pharmaceutical Development, Pharmacovigilance and Cosmetovigilance, Medicinal Chemistry and Drug Discovery, Industrial Pharmacy, Pharma Analytical Techniques and Instrumentation, Radiopharmaceuticals, Pharmaceutics and Novel Drug Delivery Systems and many more.. The conference invites delegates from Biopharma laboratories, Pharmacists, Academicians, Clinicians, Researchers, Healthcare professionals, students, business delegates and Young researchers across the globe providing a better podium, interconnecting the latest research, technological developments in the arena as well as therapeutic aspects.

Why to attend?

  • To meet people and organizations addressing these same key issues.
  • To meet people with whom you’ve established a relationship on social media.   
  • To learn about job, internship, project and other work-based possibilities.
  • To learn about fellowship and grant opportunities relevant to your area(s) of interest.
  • To gain insight into the experiences of others who face challenges similar to yours.
  • To learn about publications and other resources relevant to your area(s) of interest.

Target Audience:

  • Directors, CEO’s of Organizations
  • Business Development Managers
  • Chief Scientific Officers
  • R&D Researchers from Biosimilar and Biologics Industries
  • Professors, Associate Professors, Assistant Professors
  • PhD Scholars
  • Patent Attorneys
  • Intellectual Property Attorneys
  • Investment Analysts
  • Association, Association presidents and professionals
  • Noble laureates in Health Care and Medicine
  • Bio instruments Professionals
  • Bio-informatics Professionals
  • Software development companies
  • Research Institutes and members
  • Supply Chain companies
  • Manufacturing Companies
  • CRO and DATA management Companies
  • Training Institutes
  • Business Entrepreneurs

Session/Tracks

Track 1 Pharmaceutical Sciences

The pharmaceutical sciences combine a broad range of scientific disciplines that are critical to the discovery and development of new drugs and therapies. Pharmaceutical Sciences is a dynamic and interdisciplinary field that aims to integrate fundamental principles of physical and organic chemistry, engineering, biochemistry, and biology to understand how to optimize delivery of drugs to the body and translate this integrated understanding into new and improved therapies against human disease. At the many of institutes internationally recognized faculty contribute to the field through inquiry into the underlying mechanisms of drug interactions with the human body and development of advanced synthetic or biologically-derived materials that can modulate these interactions in pursuit of better and safer therapies and drug products.

Track 2:  Pharmaceutical Nanotechnology

Drug particles in the nanometer size range have unique characteristics that can lead to enhanced performance in a variety of dosage forms. Formulated correctly, particles in this size range are resistant to settling and can have higher saturation solubility, rapid dissolution, and enhanced adhesion to biological surfaces, thereby providing a rapid onset of therapeutic action and improved bioavailability. Scientists at Cirrus Pharmaceuticals, Inc. use nanotechnology to approach classical and novel drug delivery applications. We provide services for producing, formulating, and characterizing nanoparticles for a wide array of applications including, but not limited to, oral, pulmonary and parenteral delivery. Pharmaceutical Nanotechnology deals with emerging new technologies for developing customized solutions for drug delivery systems. 

Track 3: Pharma and Biotech Financial Outlook

The last few years have been a positive period overall for both the pharmaceutical and biotechnology industries. Most importantly, there has been a renaissance with regard to the increase in the number of new drugs approved and under development for the two segments of the business.

Many of these innovations are driven by new research methods and the growth of new therapeutic options, such as immune-related oncology drugs, personalized medicine, stem cells, and biologics. We are also witnessing the development of a greater number of drugs that cure diseases rather than just extend life.

Track 4: Drug Targeting and Design

The most fundamental goal in drug design is to predict whether a given molecule will bind to a target and if so how strongly. Molecular mechanics or molecular dynamics are most often used to predict the conformation of the small molecule and to model conformational changes in the biological target that may occur when the small molecule binds to it. The therapeutic response of a drug depends upon the interaction of drug molecules with a cell on cell membrane related biological events at receptor sites in a concentration-dependent manner. Selective and effective localization of the pharmacologically-active moiety at pre-identified target(s) in therapeutic concentration, while restricting its access to non-target(s) normal cellular linings, thus minimizing toxic effects and maximizing the therapeutic index accounts from effective and efficient drug delivery

Track: 5: BioPharmaceuticals

Biopharmaceutical Science contains a study of the drug discovery and their development, and along with their properties, both physical and chemical. It also deals with the biological effects of the drugs like onset and duration of action along with their intensity in the body. Biopharmaceutics help in calculating the bioavailability and therapeutic activity of the drugs in the body.

Track 6: Pharmacogenomics

The branch of genetics concerned with determining the likely response of an individual to therapeutic drugs. Its name reflects it’s combining of pharmacology and genomics. It deals with the influences such as acquired and inherited genetic variation on drug response in patients by correlating gene expression or single-nucleotide polymorphisms with pharmacokinetics and pharmacodynamics (drug absorption, distribution, metabolism, and elimination), as well as drug receptor target effects.

Track 7: Pharmaceutical Pre-formulation Studies

Preformulation begins when a newly produced drug shows the sufficient pharmacologic promise in the animal models to warrant evaluation in the man. And these studies mainly focus on the physicochemical properties of the new compound that could affect drug performance such as action and also in drug development.

Track 8: Pharmaceutical Research and Development

For developing a new medicine it will take nearly 10-15 years and on average and costs an average of $2.6 billion. In discovery, the procedure comprises the initial stages of research, which are intended to recognize an investigational drug and perform primary tests in the lab. This first stage of the process takes three to six years. By the end, investigators hope to identify a capable drug aspirant to further study in the lab and in animal models, and then in people. These developments offer great ability, but also add complexity to the R&D process. In order to ensure the safety and efficacy of personalized therapies that are used along with diagnostics, clinical trial protocols must be improved and increased.

Track 9: Good Manufacturing Practices (GMP)

Good Manufacturing Practice is the part of quality management which ensures that products are consistently produced and controlled according to the quality standards appropriate to their intended use and as required by the marketing authorization, clinical trial authorization or product specification. Good Manufacturing practices conference aims at both production and Quality Control. Current Good Manufacturing Practices (cGMP) is aimed primarily at managing and minimizing the risks inherent in pharmaceutical manufacture to ensure the quality, safety, and efficacy of products. FDA regulates the quality of pharmaceuticals very carefully. Current Trends in the FDA is the main regulatory standard for ensuring pharmaceutical quality.

Track 10: Importance of Audit in Pharmaceutical Industry

International Organization for Standardization (ISO) 9000 requirements do not have the same status of “the law” in the U.S. as do requirements listed in the Code of Federal Regulations (CFR). Because 21 CFR 210 and 211 have legal status, the U.S. Justice Department has extensive powers to ensure compliance. For example, product in the marketplace can be seized, fines can be levied, and personal liability can be assigned. So, management must understand that auditing must be taken seriously, and the requirements listed are just that – requirements. While audits are the common place in the pharmaceutical industry, the preparedness for those events varies. The companies that develop a risk-based approach to audits are able to remain competitive while meeting quality and government compliance standards on a regular basis. Conversely, the companies that have not implemented strong processes are putting themselves at risk for non-compliance. According to the Federal Food, Drug and Cosmetic Act, “Registered domestic drug establishments shall be inspected by the FDA at least once every two years.” Under some conditions the inspections may be even more frequent, As regulations become more stringent, regulatory authorities are likely to step up audits which is even more reason for companies to be prepared.

Track 11: Clinical Trials on Biopharmaceutical Products

In the fields of prescription, biotechnology, and pharmacology, sedate revelation is the procedure by which new candidate medications are found. Generally, medications were found through recognizing the dynamic fixing from customary cures or by fortunate revelation. Later compound libraries of manufactured little particles, characteristic items or extracts were screened in place cells or entire life forms to recognize substances that have an alluring remedial impact in a procedure known as traditional pharmacology. Since the sequencing of the human genome which permitted fast cloning and amalgamation of vast amounts of cleaned proteins, it has ended up basic practice to utilize high throughput screening of expansive mixes libraries against confined organic targets which are speculated to be illness altering in a procedure known as a turn around pharmacology. Hits from these screens are then tried in cells and after that in creatures for adequacy.

Tack 12: Challenges In Pharmaceutical Formulations

This track includes Pharmaceutical Formulation which is the process in which different chemical substances i.e., active chemical substances will combine together to produce a medical compound i.e., medical drug. This process involves the production of drug which characterized by two things: Stability of the product, second Acceptability to the patient. Formulation studies focus on factors like particle size, polymorphism, pH and solubility, in order to check whether these factors will effect  the bioavailability of the drug or not. Pharmaceutical Formulations include Ophthalmic Formulation, Paediatric Formulation Development, Topical Formulation, and Medication Formulation.

Track 13: Active Pharmaceutical Ingredients

The API market in the US is as expected growing at a CAGR of 7% over the period 2014-2019. The market research and analysis estimates that in terms of geographic regions, the Americas will be the major revenue contributor to the active pharmaceutical ingredients market throughout the next four years. The increasing demand for generic drugs from countries such as the US, the growth in aging population, and the presence of an organized R&D structure for drug development are some of the major factors that will drive the growth of the market in this region.  The key vendors in this sector are Abbott Laboratories, Aurobindo Pharma, Mylan, and Teva Pharmaceutical Industries.

Track 14: Advancements In Pharmaceutical Biotechnology

The term is Pharmaceutical Biotechnology which is the branch of science that deals with all the technologies required for manufacturing, producing and registration of biological drugs. Pharmaceutical Biotechnology is an increasingly essential area of science and technology. The Pharmaceutical Biotechnology has largely spread area, ranging from many ethical issues to changes in healthcare practices and a significant contribution to the development of the national economy. Biotech drug makers mainly use those microorganisms or highly complex proteins from genetically-modified living cells as components in medications to treat various diseases and conditions, from cancer to rheumatoid arthritis to multiple sclerosis.

Track 15: Approaches In Pharmaceutical Nanotechnology

This term Nano pharmaceutical gives an ability to identify the diseases at very earlier stages and the diagnostic applications can build upon the conventional procedures using nanoparticles. Nano pharmaceuticals is considered as an emerging field where the sizes of the drug molecule or a therapeutic delivery system work at a  Nanoscale. In the pharmaceutical industry, a never-ending issue is a difficulty of delivering the appropriate dose of a particular active medication to the specific diseased site. Nanopharmaceuticals have enormous potential in addressing this failure of traditional therapeutics which offers site-specific targeting of active agents.

Market Analysis

Pharm Sci 2019 takes immense pleasure to invite you all to be a part of this meeting which will focus on current trends and emerging issues in Formulations. This ConferenceSeries Ltd Conference desideratum is to render an intriguing forum and vibrant opportunity for researchers to share their original research results and practical experiences, at the same time absorb knowledge from works being done around the corners of the world. Apart from researchers, professors, biopharmaceutical industry practitioners, private and public investors, and students are also most welcome to get themselves inbuilt to the rays of novel happenings on Pharmaceutical.

The major objective of the conference is to emphasize the importance of Formulations, explore recent advancements, and research by making room to experts and researchers from around the globe.  To increase the interactive nature of the conference, the program is a mixture of Prompt keynote presentations, Poster Presentation, Oral talks and Exhibitions. We invite you to join us at the Formulations-2019, where you will be sure to have a meaningful experience with scholars. All the members of Formulations-2019 organizing committee look forward to meet you at Seoul, South Korea

Importance and Scope:

For the preclinical development stage, the selection of suitable formulations is an important decision in the development of pharmaceutical products. In practice, formulation consists of the manufacturing process, selecting the excipients and evaluating the formulations obtained using physicochemical and pharmacotechnical tests. These tests allow selecting, optimizing and evaluating pharmaceutical preparations based on pre-established specifications.

Market Analysis:

Pharmaceuticals represented a US$300 billion-a-year market globally as of 2015, the World Health Organization states. The global pharmaceutical market is expected to surpass US$400 billion by 2018, with the ten largest pharmaceutical companies collectively commanding about a third of the market. Companies in the pharmaceutical industry are characterized by their sizeable expenditure on R&D and marketing initiatives in a bid to rake in more revenue. The development of biopharmaceuticals represents a milestone for the industry and personalized therapies carry immense promise in the near future.

Although mature markets continue to account for over half of all global revenue of the pharmaceutical industry, both large and niche pharmaceutical companies are now waking up to the lucrative potential that lies in growth markets. Costs associated with bringing new molecules to the commercial space are progressively rising. To add to this, new medicines launches have continued to chart a flat graph. This could, however, also be an enormous opportunity for pharmaceutical companies in both mature and growth markets.

Conference Highlights:

  • Pharmaceutical Sciences
  • Pharmaceutical Nanotechnology
  • Pharma and Biotech Financial Outlook
  • Drug Targeting and Design
  • Bio Pharmaceuticals
  • Pharmacogenomics
  • Pharmaceutical Pre-formulation Studies
  • Pharmaceutical Research and Development
  • Good Manufacturing Practices (GMP)
  • Importance of Audit in Pharmaceutical Industry
  • Clinical Trials on Biopharmaceutical Products
  • Challenges In Pharmaceutical Formulations
  • Active Pharmaceutical Ingredients
  • Advancements In Pharmaceutical Biotechnology

To Collaborate Scientific Professionals around the World

Conference Date January 30-31, 2019

Speaker Opportunity

Supported By

Pharmaceutica Analytica Acta Pharmaceutical Regulatory Affairs: Open Access Journal of Pharmaceutical Sciences & Emerging Drugs

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by